← 治験一覧に戻る
日本人に対するデノスマブ療法の効果
基本情報
- NCT ID
- NCT02491515
- ステータス
- 不明
- 試験のフェーズ
- -
- 試験タイプ
- 観察
- 目標被験者数
- 500
- 治験依頼者名
- Tomidahama Hospital
概要
In this study, the investigators would like to analyze the bone mineral density (BMD) , bone turnover makers, and fracture prevention effects of denosumab in Japanese patients under clinical practice. The participants are treated in the investigators hospital, who are under severe osteoporotic condition. The main objective of this study is to investigate effects of denosumab. The researchers also investigate the effects of Effects of previous osteoporotic therapy to denosumab treatment. In this study, the investigators analyse the determinants of subsequent BMD increase and fracture preventing effect by teriparatide.
対象疾患
Osteoporosis
介入
Denosumab(DRUG)
依頼者(Sponsor)
Tomidahama Hospital(OTHER)
実施施設 (1)
医療法人 富田浜病院
Yokkaichi, Mie-ken, Japan(RECRUITING)